ALGN
Price
$135.21
Change
-$0.79 (-0.58%)
Updated
Oct 24 closing price
Capitalization
9.8B
3 days until earnings call
Intraday Buy/Sell Signals
BAX
Price
$23.02
Change
+$0.03 (+0.13%)
Updated
Oct 24 closing price
Capitalization
11.82B
4 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ALGN vs BAX

Header iconALGN vs BAX Comparison
Open Charts ALGN vs BAXBanner chart's image
Align Technology
Price$135.21
Change-$0.79 (-0.58%)
Volume$864.35K
Capitalization9.8B
Baxter International
Price$23.02
Change+$0.03 (+0.13%)
Volume$3.72M
Capitalization11.82B
ALGN vs BAX Comparison Chart in %
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. BAX commentary
Oct 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Buy and BAX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 26, 2025
Stock price -- (ALGN: $135.21 vs. BAX: $23.02)
Brand notoriety: ALGN: Notable vs. BAX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 70% vs. BAX: 63%
Market capitalization -- ALGN: $9.8B vs. BAX: $11.82B
ALGN [@Pharmaceuticals: Other] is valued at $9.8B. BAX’s [@Pharmaceuticals: Other] market capitalization is $11.82B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $193.74B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileBAX’s FA Score has 2 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • BAX’s FA Score: 2 green, 3 red.
According to our system of comparison, BAX is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 5 TA indicator(s) are bullish while BAX’s TA Score has 6 bullish TA indicator(s).

  • ALGN’s TA Score: 5 bullish, 3 bearish.
  • BAX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, BAX is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а +3.65% price change this week, while BAX (@Pharmaceuticals: Other) price change was -0.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.27%. For the same industry, the average monthly price growth was +3.28%, and the average quarterly price growth was +11.91%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

BAX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.27% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($11.8B) has a higher market cap than ALGN($9.8B). BAX has higher P/E ratio than ALGN: BAX (87.85) vs ALGN (22.84). BAX YTD gains are higher at: -19.671 vs. ALGN (-35.154). BAX has higher annual earnings (EBITDA): 1.04B vs. ALGN (793M). BAX has more cash in the bank: 1.69B vs. ALGN (901M). ALGN has less debt than BAX: ALGN (123M) vs BAX (9.73B). BAX has higher revenues than ALGN: BAX (10.9B) vs ALGN (3.97B).
ALGNBAXALGN / BAX
Capitalization9.8B11.8B83%
EBITDA793M1.04B77%
Gain YTD-35.154-19.671179%
P/E Ratio22.8487.8526%
Revenue3.97B10.9B36%
Total Cash901M1.69B53%
Total Debt123M9.73B1%
FUNDAMENTALS RATINGS
ALGN vs BAX: Fundamental Ratings
ALGN
BAX
OUTLOOK RATING
1..100
2034
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
8831
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for ALGN (73). This means that BAX’s stock grew somewhat faster than ALGN’s over the last 12 months.

BAX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ALGN (100). This means that BAX’s stock grew similarly to ALGN’s over the last 12 months.

BAX's SMR Rating (100) in the Medical Specialties industry is in the same range as ALGN (100). This means that BAX’s stock grew similarly to ALGN’s over the last 12 months.

BAX's Price Growth Rating (64) in the Medical Specialties industry is in the same range as ALGN (65). This means that BAX’s stock grew similarly to ALGN’s over the last 12 months.

BAX's P/E Growth Rating (31) in the Medical Specialties industry is somewhat better than the same rating for ALGN (88). This means that BAX’s stock grew somewhat faster than ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNBAX
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
51%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 2 days ago
52%
Declines
ODDS (%)
Bearish Trend 16 days ago
72%
Bearish Trend 16 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLRG38.310.26
+0.69%
Fidelity U.S. Multifactor ETF
UPAR15.680.06
+0.37%
UPAR Ultra Risk Parity ETF
PJAN46.150.12
+0.26%
Innovator US Equity Power Buff ETF™ Jan
CPSM28.390.03
+0.11%
Calamos S&P 500 Str Alt Prt ETF-May
EQLT30.50N/A
N/A
iShares MSCI Emerging Mkts Qual Fac ETF

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+0.13%
ALGN - BAX
72%
Closely correlated
-0.58%
LUNG - BAX
53%
Loosely correlated
+3.14%
STE - BAX
51%
Loosely correlated
-0.45%
SOLV - BAX
51%
Loosely correlated
-1.15%
SYK - BAX
51%
Loosely correlated
-0.33%
More